Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19

BACKGROUND: Safe provision of systemic anti-cancer treatment (SACT) during the COVID-19 pandemic remains an ongoing concern amongst clinicians. METHODS: Retrospective analysis on uro-oncology patients who continued or started SACT between 1st March and 31st May 2020 during the pandemic (with 2019 as...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Alfred Chung Pui, Karampera, Christina, Khan, Muhammad, Russell, Beth, Moss, Charlotte, Monroy-Iglesias, Maria J., Thillai, Kiruthikah, Josephs, Debra Hannah, Pintus, Elias, Rudman, Sarah, Van Hemelrijck, Mieke, Dolly, Saoirse, Enting, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051846/
https://www.ncbi.nlm.nih.gov/pubmed/35488333
http://dx.doi.org/10.1186/s12894-022-01023-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051846/
https://www.ncbi.nlm.nih.gov/pubmed/35488333
http://dx.doi.org/10.1186/s12894-022-01023-6

Ejemplares similares